Results 121 to 130 of about 3,197,787 (235)
Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy [PDF]
, 2016 Chia-Hsien Wu +8 more
openalex +1 more source
British Journal of Pharmacology, EarlyView.Abstract Background and Purpose Preclinical studies suggest that highly selective dopamine D3 receptor (D3R) antagonists or partial agonists hold promise for treating substance use disorders. However, their limited effectiveness in reducing cocaine self‐administration is a major drawback.
Omar Soler‐Cedeño +9 more
wiley +1 more source
Diabetic ketoacidosis and severe hypertriglyceridaemia as a consequence of an atypical antipsychotic agent [PDF]
, 2016 Kirsten Hepburn +1 more
openalex +1 more source
Clinical Endocrinology, EarlyView.ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder +5 more
wiley +1 more source
Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents [PDF]
, 2017 Tomomi Sanomachi +9 more
openalex +1 more source
An overview of insulin therapy for the non‐specialist
Diabetes, Obesity and Metabolism, EarlyView.Abstract Nearly all health professionals, whatever their practice or speciality, now have contact with a significant number of insulin‐using people with diabetes. People with type 1 diabetes are nearly universally managed on more complex insulin regimens, increasingly with complex support technology, and with some understanding of the concepts ...
Philip D. Home
wiley +1 more source